Ordóñez N G, Ayala A G, Raymond A K, Plager C, Benjamin R S, Samaan N A
Department of Pathology, University of Texas M. D. Anderson Hospital, Houston 77030.
Arch Pathol Lab Med. 1989 Apr;113(4):416-9.
Production of human chorionic gonadotropin by sarcomas is an uncommon phenomenon that has rarely been documented. A case of a 26-year-old woman with osteosarcoma of the left fibula and high levels of serum beta-human chorionic gonadotropin (beta-HCG) is described. Immunoperoxidase staining showed numerous tumor cells reacting with the beta-HCG antibody. Immunohistochemical studies performed on ten additional osteosarcomas demonstrated another case in which some tumor cells presented immunoreactivity for beta-HCG. These results indicate that beta-HCG may be used as a marker of persistent or recurrent disease in those uncommon cases of osteosarcoma in which serum levels of beta-HCG are elevated at the onset of treatment.
肉瘤产生人绒毛膜促性腺激素是一种罕见现象,鲜有文献记载。本文描述了一例26岁患有左腓骨骨肉瘤且血清β-人绒毛膜促性腺激素(β-HCG)水平升高的女性病例。免疫过氧化物酶染色显示大量肿瘤细胞与β-HCG抗体发生反应。对另外10例骨肉瘤进行的免疫组织化学研究表明,还有一例中一些肿瘤细胞呈现β-HCG免疫反应性。这些结果表明,在治疗开始时血清β-HCG水平升高的那些罕见骨肉瘤病例中,β-HCG可作为持续性或复发性疾病的标志物。